Application Study of Individualized Mechanical Power Titration Strategy Based on PiCCO (Pulse Index Continuous Cardiac Output) Monitoring Parameters in ARDS Patients
1 other identifier
observational
130
1 country
1
Brief Summary
Based on PiCCO combined with MP, the optimal mechanical power setting of the ventilator for ARDS patients in normal supine/prone position is determined to reduce the damage to lung function during mechanical ventilation. By detecting peripheral serum NLRP3 and related inflammatory markers in ARDS patients, the relationship between NLRP3 and lung injury caused by mechanical ventilation was studied.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 4, 2025
CompletedFirst Submitted
Initial submission to the registry
August 12, 2026
CompletedFirst Posted
Study publicly available on registry
September 24, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2028
September 24, 2026
September 1, 2026
2.9 years
August 12, 2026
September 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
mechanical power
deep sedation, elimination of spontaneous breathing, measurement via ventilator.Mechanical power (MP) was calculated from the median ventilator parameters via the following equation: mechanical power (J/min) = 0.098× RR × Vt × (PIP - 0.5(Pplateau-PEEP)), where PIP =peak inspiratory pressure. The MP was normalized to the predicted body weight (norMP) = MP/PBW,where PBW was the predicted body weight measured in kilograms.
Data were obtained within the first hour post-intubation, at 8:00 AM (±1 h) daily for the subsequent three consecutive days, and during position changes (prone to supine or supine to prone) within these three days.
Study Arms (2)
Prone ventilation group
non-Prone ventilation group
non-Prone ventilation group
non-Prone ventilation
Interventions
Judgement of Prone Position Therapy Based on Oxygenation Index
Eligibility Criteria
The research plan includes 130 patients. Divide into two groups, with 65 cases in each group. A: ARDS patients who use conventional ventilation during mechanical ventilation; B: ARDS patients who use prone position ventilation during mechanical ventilation.
You may qualify if:
- Admission to ICU
- Accept mechanical ventilation, with an expected duration of more than 3 days
- Diagnose 'ARDS' and meet the criteria for mild, moderate, and severe diagnosis
- Age over 18 years old
- Voluntarily participate in the study and sign an informed consent form (if the patient has consciousness disorders, it can be signed by a legal representative)
You may not qualify if:
- There are contraindications for PiCCO monitoring
- Pregnant or lactating women
- Recently (within one month) participated in other interventional clinical studies
- Expected death within 48 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Xiamen Hospital of Traditional Chinese Medicine
Xiamen, Fujian, 361009, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Department
Study Record Dates
First Submitted
August 12, 2026
First Posted
September 24, 2026
Study Start
November 4, 2025
Primary Completion (Estimated)
September 30, 2028
Study Completion (Estimated)
September 30, 2028
Last Updated
September 24, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- The IPD and supporting information will be available starting from 1 December 2028 to 31 December 2029.
- Access Criteria
- Access is limited to qualified non-commercial academic researchers. Approved users can obtain anonymized IPD and full trial supporting documents including analysis reports. Applicants shall submit a research application for committee review first, and then get secure platform access upon approval.
No raw individual-level participant data will be publicly shared. Upon reasonable scientific request and after signing a data-use agreement, de-identified aggregated clinical data may be provided. No identifiable personal information including names, ID numbers, addresses or contact information will be released.